FLGT

FLGT

USD

Fulgent Genetics Inc. Common Stock

$22.880-0.060 (-0.262%)

Precio en Tiempo Real

Healthcare
Diagnostics & Research
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$22.940

Máximo

$23.100

Mínimo

$22.631

Volumen

0.01M

Fundamentos de la Empresa

Capitalización de Mercado

700.3M

Industria

Diagnostics & Research

País

United States

Estadísticas de Negociación

Volumen Promedio

0.22M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $14.57Actual $22.880Máximo $24.64

Noticias Relacionadas

Analyst Upgrades

UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30

UBS analyst Lu Li upgrades Fulgent Genetics from Neutral to Buy and raises the price target from $20 to $30.

Ver más
UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30
Analyst Upgrades

Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21

Piper Sandler analyst David Westenberg maintains Fulgent Genetics with a Neutral and lowers the price target from $23 to $21.

Ver más
Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21
Earnings Call Transcripts

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Ver más
Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript
BusinessWire

Fulgent Reports Second Quarter 2025 Financial Results

Core Revenue of $81.7 million grows 16% year-over-year Raising Full Year 2025 Core Revenue Guidance to $320 million GAAP gross profit of $34.4 million, or GAAP gross margin of 42.1%; Non-GAAP gross profit of

Ver más
Fulgent Reports Second Quarter 2025 Financial Results

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.